490 filings
EFFECT
NVCN
Neovasc Inc
3 Aug 23
Notice of effectiveness
12:15am
15F-12B
NVCN
Neovasc Inc
24 Apr 23
Securities registration termination (foreign)
4:15pm
6-K
NVCN
Neovasc Inc
12 Apr 23
Current report (foreign)
1:10pm
6-K
NVCN
Neovasc Inc
11 Apr 23
Current report (foreign)
9:18am
RW
NVCN
Neovasc Inc
11 Apr 23
Registration withdrawal request
9:11am
F-10POS
lm94yjyc3x1y as9r
11 Apr 23
Automatic registration of securities (post-effective amendment, Canada)
9:08am
POS AM
lnkgfafr4u
11 Apr 23
Prospectus update (post-effective amendment)
9:06am
S-8 POS
jqp6zb7 1kea9cnzr
11 Apr 23
Registration of securities for employees (post-effective amendment)
9:05am
25-NSE
0qmb c9ltc6b0tip
11 Apr 23
Exchange delisting
8:47am
6-K
d8ffl
11 Apr 23
Shockwave Medical Completes Acquisition of Neovasc
8:20am
6-K
5ggfa744onc fd449ju
31 Mar 23
Current report (foreign)
4:26pm
6-K
k220lb fgsziu0lbv5
9 Mar 23
Current report (foreign)
4:25pm
6-K
gi4hkk
6 Mar 23
Neovasc Shareholders Approve Acquisition by Shockwave Medical
5:46pm
6-K
bu24jmx3n
10 Feb 23
Current report (foreign)
4:05pm
6-K
bglzhbb0nf 9i17vs
1 Feb 23
Neovasc Announces German Reimbursement Renewal
9:06am
6-K
noom91yoiu 5hu
27 Jan 23
Current report (foreign)
4:05pm
6-K
lcyuxnvd49vrcxw7u8
18 Jan 23
Material Change Report
4:05pm
6-K
1j9a5q7esb5 pvaev
17 Jan 23
Current report (foreign)
5:19pm
6-K
0b9if
17 Jan 23
Shockwave Medical to Acquire Neovasc
9:28am
6-K
fetosuyqf3
28 Nov 22
Neovasc Announces Progress on COSIRA-II Clinical Trial
5:12pm